524
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy

, , , , & ORCID Icon
Pages 1281-1298 | Received 25 Jan 2023, Accepted 11 Mar 2023, Published online: 15 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Qing-rui Qi, Huan Tian, Bao-sen Yue, Bing-tao Zhai & Feng Zhao. (2024) Research Progress of SN38 Drug Delivery System in Cancer Treatment. International Journal of Nanomedicine 19, pages 945-964.
Read now
Mei Cong, Houjun Pang, Guangxing Xie, Feifei Li, Chunxiao Li, Hao Sun, Shaoyou Yang & Weidong Zhao. (2023) Engineering of Amphiphilic Erlotinib Analogue as Novel Nanomedicine for Non-Small Cell Lung Cancer Therapy. International Journal of Nanomedicine 18, pages 6367-6377.
Read now

Articles from other publishers (7)

Tahta Amrillah, Bintang Adji Notodidjojo, Mohammad Kalimanjaro, Rangga Adhi Prastika, Azka Muhammad Nurrahman, Ahmad Taufiq, Djoko Santoso & Dwi Setyawan. (2024) Crafting Iron Oxides for Next-Generation Biomedical Applications. Crystal Growth & Design 24:13, pages 5834-5864.
Crossref
Chengzhen Pan, Chi Zhang, Zonghan Lin, Zhou Liang, Yinhang Cui, Zhihao Shang, Yuanxun Wei & Feng Chen. (2024) Disulfidptosis-related Protein RPN1 may be a Novel Anti-osteoporosis Target of Kaempferol. Combinatorial Chemistry & High Throughput Screening 27:11, pages 1611-1628.
Crossref
Nuo Li, Ludan Zhang, Kaijun Sun, Junheng Liu, Zixuan Wang, Yujing Wang, Huinan Lu, Wenjun Xiang, Hailin Yang, Rupei Tang & Guoqing Yan. (2024) pH-Sensitive Nanodrug Self-Assembled from Aliphatic 5-Fluorouracil Derivative and Doxorubicin for Synergistic Cancer Therapy. ACS Applied Nano Materials 7:9, pages 10419-10428.
Crossref
Debojit Chakraborty, Anindita Sengupta, Jayanta Bhattacharyya & Josemon Jacob. (2024) Facile synthesis and polymerization of 1,4,5-oxadithiepan-2-one for disulfide-based redox-responsive drug delivery. Polymer 298, pages 126920.
Crossref
Matilde Tubertini, Luca Menilli, Celeste Milani, Cecilia Martini, Maria Luisa Navacchia, Marta Nugnes, Manuela Bartolini, Marina Naldi, Daniele Tedesco, Elisa Martella, Andrea Guerrini, Claudia Ferroni, Francesca Moret & Greta Varchi. (2024) HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration. Frontiers in Chemistry 12.
Crossref
Yanhua Zhang, Hui Xu, Yue Li, Yang Sun & Xiaochun Peng. (2023) Advances in the treatment of pancreatic cancer with traditional Chinese medicine. Frontiers in Pharmacology 14.
Crossref
Yi Dai, Meng Qian & Yan Li. (2023) Structural Modification Endows Small-Molecular SN38 Derivatives with Multifaceted Functions. Molecules 28:13, pages 4931.
Crossref